Monday, March 8, 2021

Vaccinations + Stimulus

Monday, March 8, 2021 - Last week’s equity markets were bumpy and spent most of the week continuing the weakness of the previous week before a solid rebound on Friday brought two of the three major U.S. equity indexes into positive territory for the week. Investors continue to feel the impact of the recent increase in bond yields and appear anxious around the timing of a higher rate environment on the horizon.

The weekend brought big news with the first reflected in reports that the U.S. is now averaging over 2M Coronavirus vaccinations per day with the expectation that this rate will continue to increase as the recently approved for emergency use, singe-dose, J&J vaccination adds to the run rate. President Biden stated last week that the U.S. will have enough vaccines for every adult by the end of May.

The second big piece of news came Saturday with the Senate passing the $1.9 trillion stimulus package which includes funding for stimulus checks, vaccine distribution, and school re-openings. It will be interesting to see how the equity markets react this week to both pieces of news offset by the pressure being felt in the last few weeks from higher rates as the 10-year U.S. Treasury yield sits just above 1.5% and is up slightly over 65 basis points since the start of the year.

For the week, the DJIA gained 563.93 to close at 31,496.30, the S&P 500, which on Monday had its largest gain (2.4%) since June 2020, gained 30.79 to close at 3,841.94 and the Nasdaq lost 272.20 to close at 12,920.15.

ETFG Quant Movers - Those ETFs who have had the largest weekly change in their respective, overall ETFG Quant ratings.

ETFG Weekly Quant Winners: The three biggest gainers in their ETFG Total Quant Scores were found in the Barclays Return on Disability ETN (RODI) up 17.82 points to 62.99, the  First Trust Dorsey Wright Focus 5 ETF (FV) up 16.07 points to 55.01 and the Reality Shares DIVCON Leaders Dividend ETF (LEAD) which added 15.38 points during the week to an ETFG Total Quant Score of 52.78.

ETFG Weekly Quant Losers: The three biggest drops in their respective ETF Quant Total Scores were found in the Volshares Large Cap ETF (VSL) dropping 17.29 points to 36.44, the Barclays Women in Leadership ETN (WIL) dropping 9.89 points to 55.02 and the Innovator IBD ETF Leaders ETF (LDRS) which lost 9.71 points to close at an ETFG Total Quant Score of 51.68 for the week.

Thanks for reading ETF Global Perspectives and have a great week!

ETFG 21 Day Free Trial: https://www.etfg.com/signup/quick
_______________________________________________________

Assumptions, opinions and estimates constitute our judgment as of the date of this material and are subject to change without notice.  ETF Global LLC (“ETFG”) and its affiliates and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively ETFG Parties) do not guarantee the accuracy, completeness, adequacy or timeliness of any information, including ratings and rankings and are not responsible for errors and omissions or for the results obtained from the use of such information and ETFG Parties shall have no liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of such information. ETFG PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall ETFG Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of the information contained in this document even if advised of the possibility of such damages. ETFG ratings and rankings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities or to make any investment decisions. ETFG ratings and rankings should not be relied on when making any investment or other business decision.  ETFG’s opinions and analyses do not address the suitability of any security.  ETFG does not act as a fiduciary or an investment advisor.  While ETFG has obtained information from sources they believe to be reliable, ETFG does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities, financial instruments or strategies mentioned herein may not be suitable for all investors.  Any opinions expressed herein are given in good faith, are subject to change without notice, and are only correct as of the stated date of their issue.  Prices, values, or income from any securities or investments mentioned in this report may fall against the interests of the investor and the investor may get back less than the amount invested.  Where an investment is described as being likely to yield income, please note that the amount of income that the investor will receive from such an investment may fluctuate.  Where an investment or security is denominated in a different currency to the investor's currency of reference, changes in rates of exchange may have an adverse effect on the value, price or income.

This publication has been prepared for general guidance on matters of interest only and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, ETF Global does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.